{"id":2771,"date":"2026-06-30T15:51:28","date_gmt":"2026-06-30T05:51:28","guid":{"rendered":"https:\/\/metronorth.health.qld.gov.au\/herston-biofabrication-institute\/?page_id=2771"},"modified":"2026-07-01T12:51:15","modified_gmt":"2026-07-01T02:51:15","slug":"vascular-research-program","status":"publish","type":"page","link":"https:\/\/metronorth.health.qld.gov.au\/herston-biofabrication-institute\/research\/vascular-research-program","title":{"rendered":"Vascular Research Program"},"content":{"rendered":"

Vascular Research Program<\/h1><\/div>

Cardiovascular and vascular diseases remain a leading cause of death and disability worldwide.<\/p>\n

Complex aortic pathologies and small-diameter vascular disease continue to present major clinical challenges, with existing surgical and endovascular treatments limited by procedural complexity, device durability, thrombosis risk, infection, and poor long-term integration with native tissue. In parallel, surgeons still have limited access to realistic patient-specific procedural rehearsal and training platforms for highly complex vascular interventions. There is a significant unmet need for clinically translatable vascular technologies that improve both surgical planning and long-term vascular reconstruction outcomes.<\/p>\n

\"\"

Dr Jason Jenkins<\/p><\/div>\n

This research is driven by a multidisciplinary collaboration between vascular surgeons, engineers, scientists, radiographers, and designers at HBI and partner clinical institutions, combining clinical insight with advanced biofabrication and manufacturing technologies, including:<\/p>\n

    \n
  • Patient-specific vascular phantoms developed from clinical imaging data for procedural planning, surgical training, and device evaluation under physiologically relevant pulsatile flow and fluoroscopic conditions.<\/li>\n
  • Advanced manufacturing and biofabrication approaches combining medical imaging, 3D printing, silicone molding, electrospinning, and biomaterial technologies.<\/li>\n
  • Development of tissue-engineered vascular grafts (TEVGs) and next-generation vascular biomaterials aimed at improving regeneration, compliance, integration, and long-term patency.<\/li>\n
  • Clinically embedded translational research supporting open and endovascular procedures, surgical education, and future regenerative vascular therapies.<\/li>\n<\/ul>\n<\/div>
    <\/div>
    <\/div>
    <\/div>\n